Therapeutic substituted pyrroles

Details for Australian Patent Application No. 2009282661 (hide)

Owner Allergan, Inc.

Inventors Old, David W.

Agent Davies Collison Cave

Pub. Number AU-A-2009282661

PCT Pub. Number WO2010/022033

Priority 61/090,336 20.08.08 US

Filing date 18 August 2009

Wipo publication date 25 February 2010

International Classifications

C07D 407/08 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 207/333 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 409/08 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

17 March 2011 PCT application entered the National Phase

  PCT publication WO2010/022033 Priority application(s): WO2010/022033

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009282667-Hearing protection apparatus with incorporated eyewear

2009282659-Topical hydrogel composition